Reports
Reports
Sale
The global vascular access devices market size was valued at USD 4.4 billion in 2023, driven by the increasing cases of obesity and diabetes across the globe. The market size is anticipated to grow at a CAGR of 6.5% during the forecast period of 2024-2032 to achieve a value of USD 7.8 billion by 2032.
Vascular access devices (VADs) are thin, flexible, tube-like equipment that helps in providing long-term access to blood vessels. VADs are also called PICCs, ports, cannulas, drips, or IVs. Vascular access devices may rescue people with cystic fibrosis who need intravenous (IV) antibiotic treatments regularly, such as during an exacerbation. There are two main categories of vascular access devices: peripherally inserted central catheters (PICC) lines and ports.
The vascular access devices market demand is primarily being driven by the rising development in the market, along with the increasing efforts by the key players. The Teleflex Incorporated, a leading global provider of medical technologies, announced that Premier has awarded them a national agreement for Hemodynamic Monitoring Products and Accessories, a national agreement for Central Venous Access, a Sole Source for AscenDrive Central Venous Access, and a Sole Source for SURPASS Central Venous Access. Teleflex’s accessibility and competitiveness are expected to be influenced positively by this. This endorsement of Teleflex's products through these agreements not only affirms the quality and reliability of their offerings but also makes Teleflex a preferred name in the market, which will directly contribute to the vascular access devices market share.
Both the companies have agreed on some special pricing and terms negotiated by Premier, which will provide added incentives for healthcare providers to choose Teleflex’s solutions, which is expected to potentially influence their purchasing decisions on a broader scale and contribute to Teleflex’s market expansion and the global vascular access devices market growth.
The market demand is also driven by the increased prevalence of chronic diseases such as heart diseases and non-communicable diseases such as depression, hypertension, and obesity among others. The increasing technological advancement of vascular access devices is a major factor driving the market growth.
Market Breakup by Device Type
Market Breakup by Mode of Insertion
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
The market growth is driven by the increased prevalence of non-communicable diseases and chronic diseases. These diseases include cancer, tuberculosis, cardiovascular disease, depression, obesity, diabetes, and hypertension, among other conditions. These medical conditions require vascular access procedures for intravenous antibiotic treatment and extraction of blood samples, among others. Due to the increased number of vascular access procedures, the market is expected to draw attention of key players to invest in manufacturing and development of advanced equipment to assist.
North America has been leading the vascular access devices market demand and is expected to dominate the market during the forecast period as well. According to the data released by the American Cancer Society, more than 1.9 million new cancer cases are expected to occur in the United States in 2023, excluding basal cell and squamous cell skin cancers. Followed by this data, cancer is expected to account for nearly 609,820 deaths in the United States. The data clearly determines that the demand for vascular access devices is expected to increase in the forecast period as a huge population is expected to be diagnosed with cancer, which will result in increased treatment demand for the condition in healthcare facilities, propelling the market growth.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Device Type |
|
Breakup by Mode of Insertion |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Vascular Access Devices Market Overview
3.1 Global Vascular Access Devices Market Historical Value (2017-2023)
3.2 Global Vascular Access Devices Market Forecast Value (2024-2032)
4 Global Vascular Access Devices Market Landscape
4.1 Global Vascular Access Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Vascular Access Devices Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
5 Global Vascular Access Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Vascular Access Devices Market Segmentation
6.1 Global Vascular Access Devices Market by Device Type
6.1.1 Market Overview
6.1.2 Central Vascular Access Devices
6.1.2.1 Peripherally Inserted
6.1.2.2 Central Catheters
6.1.2.3 Percutaneous Non-tunneled Catheters
6.1.2.4 Other Central Vascular Access Devices
6.1.3 Peripheral Vascular Access Devices
6.1.3.1 Peripheral Catheter
6.1.3.2 Midline Catheter
6.1.3.3 Other Peripheral Vascular Access Devices
6.1.4 Accessories
6.2 Global Vascular Access Devices Market by Mode of Insertion
6.2.1 Market Overview
6.2.2 Intravenous
6.2.3 Subcutaneous
6.3 Global Vascular Access Devices Market by Application
6.3.1 Market Overview
6.3.2 Administration of Drugs
6.3.3 Administration of Fluid and Nutrition
6.3.4 Diagnostics and Testing
6.3.5 Other Applications
6.4 Global Vascular Access Devices Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Speciality Clinics
6.4.4 Home Healthcare
6.4.5 Others
6.5 Global Vascular Access Devices Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Vascular Access Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Vascular Access Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Vascular Access Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Vascular Access Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Vascular Access Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Becton, Dickinson and Company
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Baxter International Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 B. Braun Melsungen AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Fresenius Medical Care AG & Co.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 NIPRO Medical Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Medtronic
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 AngioDynamics
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Teleflex Incorporated
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Vygon SA
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Terumo Medical Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Cardinal Health
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Abbott
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Boston Scientific Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 BIOTRONIK, Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Shanghai Puyi Medical Instruments Co, Ltd
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Vascular Access Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 4.4 billion in 2023, driven by the rapid innovation and development in the market.
The market is anticipated to grow at a CAGR of 6.5% during the forecast period of 2024-2032 and is likely to reach a market value of USD 7.8 billion by 2032.
The increasing prevalence of chronic diseases and heart-related issues is a major factor driving the market growth.
The increasing technological advancement in the development of such devices is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Different types of vascular access devices include central vascular access devices, peripheral vascular access devices, and accessories.
Different modes of insertion include intravenous and subcutaneous.
They find wide applications in the administration of drugs, administration of fluid and nutrition, diagnostics and testing, among other applications.
The end users in the market include hospitals, speciality clinics, and home healthcare, among others.
Key players involved in the market are Becton, Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Fresenius Medical Care AG & Co., NIPRO Medical Corporation, Medtronic, AngioDynamics, Teleflex Incorporated, Vygon SA, Terumo Medical Corporation, Cardinal Health, Boston Scientific Corporation, BIOTRONIK, Inc., Shanghai Puyi Medical Instruments Co, Ltd, and Abbott.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.